AEP Amer Power posts 26 percent Q4 2025 earnings beat shares dip modestly on soft investor reaction Alnylam Pharmaceuticals Inc ALNY Phase 2 Diabetes Drug Progress and SP 500 Contender Status Lift Bullish Outlook MLAAW Mountain key quarterly earnings metrics remain undisclosed as final audit work nears completion